"Is life worth living? It all depends on the
Unlike breast or prostate cancer, most people diagnosed with liver cancer will die within the year. Ninety-five percent of liver cancers are called hepatocarcinomas.
About 600,000 worldwide hepatocarcinomas will be diagnosed in 2011.
The February 4, 2011 issue of the journal Human Pathology contains a study in which a cow's milk hormone, insulin-like growth factor-1 (IGF-1) is identified as a key factor in the growth and proliferation of human liver cancer cells.
The research was performed by scientists at the Cleveland Clinic's Department of Anatomic Pathology (named as one of the three best hospitals in America by U.S. News & World Report along with Johns Hopkins and The Mayo Clinic).
The researchers wrote:
The Cleveland Clinic treats 2 million patients each year. In this study, pathologists noted that IGF-I expression was noted in nearly 60 percent of the livers of those undergrowing liver transplants, but in less than 7 percent of adjacent non-tumerous liver tissue.
The authors conclude:
"Targeted therapies against insulin-like growth factor receptors may be justifiable in the treatment of hepatocellular carcinoma."
It is refreshing to see scientists with half-a-clue. What will be their future wake-up call, and when will they finally make the connection to cow's milk?
The 22nd century targeted therapy will be to target IGF-I in cow's milk as the key factor in every human cancer. That and nothing less will be the elusive holy grail cure for cancer. The pre-cancer therapy? One word: Notmilk!